Loading…

Preparation and Antidiabetic Activity of Cyclic Sulfonylthiourea Derivatives

3-Substituted 5-methyl-1-{p-[(3, 5-dimethyl)pyrazol-1-yl]-, 5-methyl-1-{p-[(5-methyl-3-carboxy)pyrazol-1-yl]-, 1-{p-[(3-methyl-5-phenyl)pyrazol-1-yl]-, and 1-{p-[(3-methyl-4-bromo-5-phenyl)pyrazol-1-yl]benzenesulfonyl}-2-thiohydantoin and their 5-methyl-2-thiohydantoin and 5, 6-dihydro-4(3H)-oxo-2(1...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 1981-08, Vol.70 (8), p.952-956
Main Authors: Soliman, Raafat, Feid-Allah, Hassan M., Mohamed, Hosny F.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:3-Substituted 5-methyl-1-{p-[(3, 5-dimethyl)pyrazol-1-yl]-, 5-methyl-1-{p-[(5-methyl-3-carboxy)pyrazol-1-yl]-, 1-{p-[(3-methyl-5-phenyl)pyrazol-1-yl]-, and 1-{p-[(3-methyl-4-bromo-5-phenyl)pyrazol-1-yl]benzenesulfonyl}-2-thiohydantoin and their 5-methyl-2-thiohydantoin and 5, 6-dihydro-4(3H)-oxo-2(1H)-pyrimidinethione derivatives were prepared for evaluation as hypoglycemic agents. Biological testing showed that some of these compounds possessed antidiabetic activity.
ISSN:0022-3549
1520-6017
DOI:10.1002/jps.2600700834